Skip To Main Content
Rezan Berkay Izgor on Muck Rack

Rezan Berkay Izgor

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rezan Berkay

Contact Rezan Berkay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Association between antidepressant use and overall survival in metastatic renal cell carcinoma treated with first-line targeted therapy

|
By Oktay Halit Aktepe, Huseyin Salih Semiz, Mustafa Erman, Suayib Yalcin, Betul Aktepe, Rezan Berkay Izgor, Shamil Rustamov, Seren Karakaya, Mehmet Hamid Boztas, Aziz Karaoglu
| Nature Verified
Abstract Depression is common among patients with metastatic renal cell carcinoma (mRCC), yet the prognostic relevance of antidepressant (AD) use during targeted therapy (TT) remains unclear. This study evaluated the association between AD use and overall survival (OS) in mRCC patients receiving first-line TT. This multicenter retrospective cohort study included 328 patients with mRCC treated with first-line TT between January 2015 and January 2025.
Open in Who Shared Issue with article?
See all 1 articles